USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
24-Nov-2005
Global
Market Research
B704-01-00-00-00
HC01147-GL-MR_05220
This research service analyses the market strategies for top pharmaceutical companies.
Executive Summary
- Executive Summary
Introduction to the Research Service
- Scope
- Exchange Rates
Pfizer
- Introduction
- SWOT Analysis
- Pharmaceutical Business
- Company Strategy
GlaxoSmithKline
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Sanofi-Aventis
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Johnson & Johnson
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Merck & Co.
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Astrazeneca
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Novartis
- Introduction
- SWOT Analysis
- Pharmaceutical Business
- Company Strategy
Bristol-Myers Squibb
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Roche
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Eli Lilly
- Introduction
- SWOT Analysis
- Pharmaceutical
- Company Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B704-01-00-00-00 |
| Is Prebook | No |
Market Strategies for Top Pharmaceutical Companies
$3,950.00
Special Price $2,962.50 save 25 %